Arrowhead Pharmaceuticals(ARWR)
PASADENA, CA
Pharmaceutical1 H-1B visas (FY2023)Focus: RNAi
Arrowhead Pharmaceuticals is a life sciences company focused on RNAi.
Gene TherapyNeurology
Funding Stage
PUBLIC
Open Jobs
4
Products & Portfolio (1)
Pipeline & Clinical Trials
N/A
Clinical Trials (1)
NCT06827288Adaptive Interventions for Emergency Department Patients With Opioid Use Disorder
N/APlozasiran
Familial ChylomicronemiaClinical Trials (1)
NCT06796426Treatment Protocol of Plozasiran in Adults With High-Risk Severe Hypertriglyceridemia (SHTG) and in Adults and Adolescents With FCS
N/AVitamin C
BurnsClinical Trials (1)
NCT05612867Low Dose Vitamin C in Burns >20% Compared to Previous Studies With High Dose Vitamin C
N/APacked Red Blood Cell Administration
Trauma InjuryClinical Trials (1)
NCT06402669Extremity Trauma At a Level 1 Trauma Center
N/ANo Intervention
COVID-19Clinical Trials (1)
NCT05897528Insulin Regulation and Severity of Severe Acute Respiratory Syndrome COVID-19 Infection
N/ANo Intervention
Rectal Foreign BodyClinical Trials (1)
NCT05888363Management and Removal of Foreign Bodies in the Emergency Department
N/ASofosbuvir and simeprevir
Hepatitis CClinical Trials (1)
NCT02485262Outcome of New Direct Acting Agents For Hepatitis C A Community Based Experience
N/AMortality and Morbidity Associated With New Onset Acute Kidney Injury in Critically Ill COVID-19 Inf
Acute Kidney InjuryClinical Trials (1)
NCT05964088Mortality and Morbidity Associated With New Onset Acute Kidney Injury in Critically Ill COVID-19 Infection Patients
N/ABoceprevir
Hepatitis C InfectionClinical Trials (1)
NCT01465516Treating Hispanic Patients Diagnosed With Hepatitis C Using Boceprevir
N/AOrthopedic Surgery
Lactate Blood IncreaseClinical Trials (1)
NCT05611398Lactate Monitoring in Traumatic Long Bone Fractures Requiring Emergent Surgical Intervention
N/AMindfulness
Depression, UnipolarClinical Trials (1)
NCT05400382Mindfulness to Reduce Post-cesarean Pain and Prevent Postpartum Depression
N/ANo Intervention
COVID-19Clinical Trials (1)
NCT05859958ABO Blood Group Type Association With COVID-19 Severity
N/ADifference in development of Acute Lung Injury in Amphetamine positive and negative patients
BurnsClinical Trials (1)
NCT05611385Amphetamine Induced Adult Respiratory Distress Syndrome
N/AARO-ATXN2 Injection
Spinocerebellar Ataxia Type 2Clinical Trials (1)
NCT06672445Study of ARO-ATXN2 Injection in Adults With Spinocerebellar Ataxia Type 2
Phase 1ARO-ANG3
DyslipidemiasClinical Trials (1)
NCT03747224Study of ARO-ANG3 in Healthy Volunteers and in Dyslipidemic Patients
Phase 1ARO-HIF2
Clear Cell Renal Cell CarcinomaClinical Trials (1)
NCT04169711Study of ARO-HIF2 in Patients With Advanced Clear Cell Renal Cell Carcinoma
Phase 1ARO-APOC3
HypertriglyceridemiaClinical Trials (1)
NCT03783377Study of ARO-APOC3 in Healthy Volunteers, Hypertriglyceridemic Patients and Patients With Familial Chylomicronemia Syndrome (FCS)
Phase 1Azithromycin Pill
InfectionsClinical Trials (1)
NCT06543290Azithromycin Before Induction
Phase 1ARO-RAGE Injection
AsthmaClinical Trials (1)
NCT05533294Study of ARO-RAGE in Healthy Subjects
Phase 1ARC-520
HealthyClinical Trials (1)
NCT02535416A Study of ARC-520 at Varying Infusion Rates in Healthy Adult Volunteers
Phase 1VSA001 injection
Healthy Adult VolunteersClinical Trials (1)
NCT05757596Study of VSA001 Injection in Chinese Healthy Adult Volunteers
Phase 1ARC-520
HealthyClinical Trials (1)
NCT01872065Safety and Tolerability Study of ARC-520 in Healthy Volunteers
Phase 1ARC-521 Injection
Hepatitis BClinical Trials (1)
NCT02797522A Study of ARC-521 Injection in Normal Adult Volunteers and Patients With Chronic Hepatitis B (CHB)
Phase 1ARC-AAT Injection
Alpha-1 Antitrypsin DeficiencyClinical Trials (1)
NCT02363946A Study of ARC-AAT in Healthy Volunteer Subjects and Patients With Alpha-1 Antitrypsin Deficiency (AATD)
Phase 1ARO-SOD1 Injection
Amyotrophic Lateral SclerosisClinical Trials (1)
NCT05949294Study of AROSOD-1 in Adult Participants With Amyotrophic Lateral Sclerosis (ALS)
Phase 1ARO-AAT Injection
Alpha 1-Antitrypsin DeficiencyClinical Trials (1)
NCT03362242Study of ARO-AAT in Normal Adult Volunteers
Phase 1ARO-CFB
IgA NephropathyClinical Trials (1)
NCT06209177Study of ARO-CFB in Adult Healthy Volunteers and Patients With Complement-Mediated Kidney Disease
Phase 1/2ARO-HSD Injection
Non-alcoholic SteatohepatitisClinical Trials (1)
NCT04202354Study of ARO-HSD in Healthy Volunteers and Patients With Non-Alcoholic Steatohepatitis (NASH) or Suspected NASH
Phase 1/2ARO-RAGE
AsthmaClinical Trials (1)
NCT05276570Study of ARO-RAGE in Healthy Subjects and Patients With Inflammatory Lung Disease
Phase 1/2ARO-INHBE
ObesityClinical Trials (1)
NCT06700538Study of ARO-INHBE in Adults With Obesity With and Without Diabetes Mellitus
Phase 1/2ARO-MUC5AC
AsthmaClinical Trials (1)
NCT05292950Study of ARO-MUC5AC in Healthy Subjects and Patients With Muco-Obstructive Lung Disease
Phase 1/2ARO-ENaC
Cystic Fibrosis, PulmonaryClinical Trials (1)
NCT04375514Study of ARO-ENaC in Healthy Volunteers and in Patients With Cystic Fibrosis
Phase 1/2ARO-HBV
Hepatitis BClinical Trials (1)
NCT03365947Study of ARO-HBV in Normal Adult Volunteers and Patients With Hepatitis B Virus (HBV)
Phase 1/2ARO-DIMERPA
Hyperlipidemia; MixedClinical Trials (1)
NCT07223658Study of ARO-DIMERPA in Adult Participants With Mixed Hyperlipidemia
Phase 1/2ARO-MMP7 Inhalation Solution
Idiopathic Pulmonary FibrosisClinical Trials (1)
NCT05537025Study of ARO-MMP7 Inhalation Solution in Healthy Subjects and Patients With Idiopathic Pulmonary Fibrosis
Phase 1/2ARO-MAPT-SC
Alzheimer DiseaseClinical Trials (1)
NCT07221344Study of ARO-MAPT-SC in Healthy Subjects and Subjects With Early Alzheimer's Disease
Phase 1/2ARO-DM1 Intravenous
Myotonic Dystrophy 1Clinical Trials (1)
NCT06138743Study of ARO-DM1 in Subjects With Type 1 Myotonic Dystrophy
Phase 1/2ARO-DUX4 for Injection
Facio-Scapulo-Humeral DystrophyClinical Trials (1)
NCT06131983Study of ARO-DUX4 in Adult and Adolescent Patients With Facioscapulohumeral Muscular Dystrophy Type 1
Phase 1/2ARO-C3
C3 GlomerulopathyClinical Trials (1)
NCT05083364Study of ARO-C3 in Adult Healthy Volunteers and Patients With Complement Mediated Renal Disease
Phase 1/2ARO-ALK7
ObesityClinical Trials (1)
NCT06937203Study of ARO-ALK7 in Adult Volunteers With Obesity With and Without Type 2 Diabetes Mellitus
Phase 1/2ARC-520 Injection
Hepatitis BClinical Trials (1)
NCT02738008Extension Study of the Safety and Efficacy of Multi-dose Intravenous ARC-520 in Patients With Chronic Hepatitis B (HBV) Infection
Phase 2Phase 2
Clinical Trials (1)
NCT03946449Study of Fazirsiran (TAK-999, ARO-AAT) in Patients With Alpha-1 Antitrypsin Deficiency Associated Liver Disease (AATD)
Phase 2ARC-520 Injection
Chronic Hepatitis BClinical Trials (1)
NCT02349126Study of ARC-520 in Patient With Chronic Hepatitis B Virus
Phase 2ARO-APOC3
DyslipidemiasClinical Trials (1)
NCT05413135Study of ARO-APOC3 in Adults With Dyslipidemia
Phase 2ARC-520
Chronic Hepatitis BClinical Trials (1)
NCT02452528Study of ARC-520 in Participants With Hepatitis B Virus e Antigen (HBeAg) Positive Chronic Hepatitis B Virus
Phase 2ARC-AAT Injection
Alpha-1 Antitrypsin DeficiencyClinical Trials (1)
NCT02900183Safety, Tolerability and Effect of ARC-AAT Injection on Circulating and Intrahepatic Alpha-1 Antitrypsin Levels
Phase 2ARC-520
Hepatitis BClinical Trials (1)
NCT02577029Study of ARC-520 With or Without Other Drugs Used in the Treatment of Chronic Chronic Hepatitis B Virus (HBV)
Phase 2ARO-RAGE
AsthmaClinical Trials (1)
NCT07241546Study of Inhaled ARO-RAGE in Allergen-induced Mild Asthma
Phase 2ARC-520
Hepatitis B, ChronicClinical Trials (1)
NCT02065336A Multicenter Study to Determine the Depth and Duration of Hepatitis B Surface Antigen (HBsAg) Reduction After Single or Multiple Doses of ARC-520, in Combination With Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection
Phase 2Fazisiran Injection
Alpha 1-Antitrypsin DeficiencyClinical Trials (1)
NCT03945292Safety, Tolerability and Pharmacodynamic Effect of Fazirsiran (TAK-999, ARO-AAT)
Phase 2Open Jobs (4)
Interview Prep Quick Facts
Portfolio: 1 approved product, 70 clinical trials
Top TAs: Rare Diseases
H-1B (2023): 1 approval
SEC Filings: 2 available
Open Roles: 4 active jobs
Portfolio Health
Launch1 (100%)
1 total products
Visa Sponsorship
Sponsors Work Visas
H-1B Petitions (FY2023)
1
Approved
0
Denied
100%
Rate
Source: USCIS H-1B Employer Data Hub